Blood-Based Biomarker for Sports Medicine Market
完整報告名稱與涵蓋範圍
Blood-Based Biomarker for Sports Medicine Market Size, Share & Trends Analysis Report By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6), By Region, And By Segment Forecasts, 2025-2034
報告摘要
In 2024, the Blood-Based Biomarker for Sports Medicine Market worldwide was assessed at USD 757.8 Million. Analysts project it will surge to USD 1,423.9 Million by 2034, at a CAGR of 7.8% spanning 2025 to 2034.
The Blood-Based Biomarker for Sports Medicine sector involves dynamics.
The market's upward path is underpinned by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Blood-based Biomarker for Sports Medicine Market Snapshot
Chapter 4. Global Blood-based Biomarker for Sports Medicine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Blood-based Biomarker for Sports Medicine Market Industry Trends
4.10. Global Blood-based Biomarker for Sports Medicine Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Blood-based Biomarker for Sports Medicine Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share By Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Dry Food (Kibble)
5.2.2. CK
5.2.3. Myoglobin
5.2.4. Lactate
5.2.5. WBC
5.2.6. Urea
5.2.7. CRP
5.2.8. Lipid and Protein Hydroperoxides
5.2.9. IL-6
5.2.10. Others
Chapter 6. Blood-based Biomarker for Sports Medicine Market Segmentation 2: Regional Estimates & Trend Analysis
6.1. Global Blood-based Biomarker for Sports Medicine Market, Regional Snapshot 2024 & 2034
6.2. North America
6.2.1. North America Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
6.2.1.1. US
6.2.1.2. Canada
6.2.2. North America Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
6.3. Europe
6.3.1. Europe Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
6.3.1.1. Germany
6.3.1.2. U.K.
6.3.1.3. France
6.3.1.4. Italy
6.3.1.5. Spain
6.3.1.6. Rest of Europe
6.3.2. Europe Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
6.4. Asia Pacific
6.4.1. Asia Pacific Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
6.4.1.1. India
6.4.1.2. China
6.4.1.3. Japan
6.4.1.4. Australia
6.4.1.5. South Korea
6.4.1.6. Hong Kong
6.4.1.7. Southeast Asia
6.4.1.8. Rest of Asia Pacific
6.4.2. Asia Pacific Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
6.5. Latin America
6.5.1. Latin America Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
6.5.1.1. Brazil
6.5.1.2. Mexico
6.5.1.3. Rest of Latin America
6.5.2. Latin America Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
6.6. Middle East & Africa
6.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
6.6.1.1. GCC Countries
6.6.1.2. Israel
6.6.1.3. South Africa
6.6.1.4. Rest of Middle East and Africa
6.6.2. Middle East & Africa Blood-based Biomarker for Sports Medicine Market Revenue (US$ Million) Estimates and Forecasts By Type, 2021-2034
Chapter 7. Competitive Landscape
7.1. Major Mergers and Acquisitions/Strategic Alliances
7.2. Company Profiles
7.2.1. . Abbott Laboratories
7.2.1.1. Business Overview
7.2.1.2. Key Product Type/Service Overview
7.2.1.3. Financial Performance
7.2.1.4. Geographical Presence
7.2.1.5. Recent Developments with Business Strategy
7.2.2. BIOMÉRIEUX
7.2.3. F. Hoffmann-La Roche Ltd.
7.2.4. ARUP Laboratories Inc.
7.2.5. Siemens Healthineers AG
7.2.6. RayBiotech, Inc
7.2.7. Thermo Fisher Scientific, Inc.
7.2.8. Bio-Rad Laboratories, Inc
7.2.9. Beckman Coulter, Inc.
7.2.10. Randox Laboratories Ltd.
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們